Community-acquired pneumonia in critically ill very old patients: a growing problem

被引:55
|
作者
Cilloniz, Catia [1 ]
Dominedo, Cristina [2 ]
Pericas, Juan M. [3 ]
Rodriguez-Hurtado, Diana [4 ]
Torres, Antoni [1 ]
机构
[1] UB, Dept Pneumol, Inst Clin Torax,SGR 911,Ciber Enfermedades Resp C, Hosp Clin Barcelona,Inst Invest Biomed August Pi, Barcelona, Spain
[2] Univ Cattolica Sacro Cuore, Dept Anesthesiol & Intens Care Med, Fdn Policlin Univ A Gemelli, Rome, Italy
[3] Univ Lleida, Clin Direct Infect Dis & Microbiol, Hosp Univ Arnau de Vilanova, Hosp Univ Santa Maria,IRBLleida, Lleida, Spain
[4] Peruvian Univ Cayetano Heredia, Dept Med, Natl Hosp Arzobispo Loayza, Lima, Peru
来源
EUROPEAN RESPIRATORY REVIEW | 2020年 / 29卷 / 155期
关键词
INFECTIOUS-DISEASES-SOCIETY; LONG-TERM MORTALITY; INTENSIVE-CARE; ELDERLY-PATIENTS; HOSPITALIZED-PATIENTS; IMPROVING OUTCOMES; THORACIC-SOCIETY; DECISION-MAKING; RISK-FACTORS; ICU;
D O I
10.1183/16000617.0126-2019
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Very old (aged >= 80 years) adults constitute an increasing proportion of the global population. Currently, this subgroup of patients represents an important percentage of patients admitted to the intensive care unit. Community-acquired pneumonia (CAP) frequently affects very old adults. However, there are no specific recommendations for the management of critically ill very old CAP patients. Multiple morbidities, polypharmacy, immunosenescence and frailty contribute to an increased risk of pneumonia in this population. CAP in critically ill very old patients is associated with higher short- and long-term mortality; however, because of its uncommon presentation, diagnosis can be very difficult. Management of critically ill very old CAP patients should be guided by their baseline characteristics, clinical presentation and risk factors for multidrug-resistant pathogens. Hospitalisation in intermediate care may be a good option for critical ill very old CAP patients who do not require invasive procedures and for whom intensive care is questionable in terms of benefit.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome
    Cilloniz, Catia
    Pericas, Juan M.
    Peroni, Hector
    Barbeta, Enric
    Gabarrus, Albert
    Torres, Antoni
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (06): : 520 - 522
  • [2] Outcomes of Critically ill Very old patients with Acute Respiratory Distress Syndrome and Community-Acquired Pneumonia
    Cilloniz Campos, Catia
    Manuel Pericas, Juan
    Peroni, Hector
    Gabarrus, Albert
    Barbeta, Enric
    Palomeque, Andrea
    Ferrer, Miquel
    Torres, Antoni
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [3] Improving care for critically ill patients with community-acquired pneumonia
    Bianchini, Monica L.
    Mercuro, Nicholas J.
    Kenney, Rachel M.
    Peters, Michael A.
    Samuel, Linoj P.
    Swiderek, Jennifer
    Davis, Susan L.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (12) : 861 - 868
  • [4] INITIAL HORMONAL AND METABOLIC PROFILE IN CRITICALLY ILL PATIENTS WITH COMMUNITY-ACQUIRED LOBAR PNEUMONIA
    FELDMAN, C
    JOFFE, B
    PANZ, VR
    LEVY, H
    WALKER, L
    KALLENBACH, JM
    SEFTEL, HC
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1989, 76 (11): : 593 - 596
  • [5] Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia
    Boselli, E
    Breilh, D
    Rimmelé, T
    Djabarouti, S
    Saux, MC
    Chassard, D
    Allaouchiche, B
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (01) : 104 - 109
  • [6] Comparative Analysis of the Host Response to Community-acquired and Hospital-acquired Pneumonia in Critically Ill Patients
    van Vught, Lonneke A.
    Scicluna, Brendon P.
    Wiewel, Maryse A.
    Hoogendijk, Arie J.
    Klouwenberg, Peter M. C. Klein
    Franitza, Marek
    Toliat, Mohammad R.
    Nuernberg, Peter
    Cremer, Olaf L.
    Horn, Janneke
    Schultz, Marcus J.
    Bonten, Marc M. J.
    van der Poll, Tom
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (11) : 1366 - 1374
  • [7] THE VALUE OF PROADRENOMEDULLIN IN CRITICALLY ILL PATIENTS WITH SEVERE COMMUNITY-ACQUIRED PNEUMONIA: AN EARLY MARKER OF RESPONSE?
    Pereira, J. M.
    Azevedo, A.
    Paiva, J. A.
    [J]. INTENSIVE CARE MEDICINE, 2014, 40 : S269 - S269
  • [8] Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia
    Meduri, G. Umberto
    Shih, Mei-Chiung
    Bridges, Lisa
    Martin, Thomas J.
    El-Solh, Ali
    Seam, Nitin
    Davis-Karim, Anne
    Umberger, Reba
    Anzueto, Antonio
    Sriram, Peruvemba
    Lan, Charlie
    Restrepo, Marcos I.
    Guardiola, Juan J.
    Buck, Teresa
    Johnson, David P.
    Suffredini, Anthony
    Bell, W. Andrew
    Lin, Julia
    Zhao, Lan
    Uyeda, Lauren
    Nielsen, Lori
    Huang, Grant D.
    [J]. INTENSIVE CARE MEDICINE, 2022, 48 (08) : 1009 - 1023
  • [9] A Systematic Review of Gene Expression Studies in Critically Ill Patients with Sepsis and Community-Acquired Pneumonia
    Viasus, Diego
    Nonell, Lara
    Restrepo, Carlos
    Figueroa, Fabian
    Donado-Mazarron, Carla
    Carratala, Jordi
    [J]. BIOMEDICINES, 2023, 11 (10)
  • [10] Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia
    G. Umberto Meduri
    Mei-Chiung Shih
    Lisa Bridges
    Thomas J. Martin
    Ali El-Solh
    Nitin Seam
    Anne Davis-Karim
    Reba Umberger
    Antonio Anzueto
    Peruvemba Sriram
    Charlie Lan
    Marcos I. Restrepo
    Juan J. Guardiola
    Teresa Buck
    David P. Johnson
    Anthony Suffredini
    W. Andrew Bell
    Julia Lin
    Lan Zhao
    Lauren Uyeda
    Lori Nielsen
    Grant D. Huang
    [J]. Intensive Care Medicine, 2022, 48 : 1009 - 1023